Old Web
English
Sign In
Acemap
>
authorDetail
>
Casey N. Aitken
Casey N. Aitken
Mayo Clinic
Pomalidomide
Everolimus
Synthetic lethality
BTK Inhibitor DTRMWXHS-12
Cancer research
1
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Patients with Relapsed/Refractory CLL, DLBCL or Other B-Cell Lymphomas
2019
Blood
Anthony R. Mato
Stephen J. Schuster
Francine M. Foss
Iris Isufi
Wei Ding
Danielle M. Brander
Andrea Sitlinger
Han W Tun
Muhamad Alhaj Moustafa
Kaitlin Kennard
Cara M King
Amber B. Koehler
Casey N. Aitken
Wei He
Albert Kearney
Min Gui
Barry Douglas Anderson
Allison C. Rosenthal
Lindsey E. Roeker
Scott F. Huntington
Show All
Source
Cite
Save
Citations (2)
1